{
    "id": 20548,
    "cites": 40,
    "cited_by": 3,
    "reference": [
        "Acemolgu, Daron and Joshua Linn. 2004. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Quarterly Journal of Economics, 119(3): 1049-1090.",
        "Alazarki, Melly. 2011. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The 10 Biggest-Selling Drugs That Are About to Lose Their Patent,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Daily Finance, Feb 27, 2011.",
        "Arora, A, L Branstetter, and C Chatterjee. 2008. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Strong Medicine: Patent Reform and the Emergence of Research-Driven Pharmaceutical Industry in India.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Bajaj, Vikas and Andrew Pollack. 2012. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093India Order Bayer to License a Patented Drug,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d New York Times, March 12, 2012.",
        "Berndt, Ernst and Iain Cockburn. 2014. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The hidden cost of low prices: limited access to new drugs in India,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Health Affairs, 33(9): 1567-75.",
        "Borrell, J.-R. (2005). Patents and the faster introduction of new drugs in developing countries. Applied Economics Letters, 12(2): 379-382.",
        "Chatterjee, Patralekha. 2005. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093India\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s new patent laws may still hurt generic drug supplies,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The Lancet, 365(9468): 1378.",
        "Chaudhuri, Sudip. 2005. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093TRIPS and Changes in Pharmaceutical Patent Regime in India,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d India Institute of Management Calcutta, working paper #535.",
        "Chaudhuri, Sudip, Chan Park and K. M. Gopakumar. 2010. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Five Years Into the Product Patent Regime: India\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s Response,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d mimeo United Nations Development Programme.",
        "Chaudhuri, Shubham, Pinelopi K. Goldberg, and Panle Gia. 2006. \"Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in India.\" American Economic Review, 96(5): 1477-1514.",
        "Dranove, David, Craig Garthwaite and Manuel Hermasillo. 2014. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Pharmaceutical Profits and the Social Value of Innovation,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d NBER Working Paper, 20212.",
        "Doshi, Tishani. 2004. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093AIDS: Drug Wars,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The Hindu, July 11, 2004, available at: http://www.hindu.com/thehindu/mag/2004/07/11/stories/2004071100160200.htm.",
        "Dugger, Cecilia. 2001. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093A Catch-22 on Drugs for the World&apos;s Poor,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The New York Times, Nov 16, 2001.",
        "Efrle, Stephen and Henry McMillan. 1990. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Media, Political Pressure, and the Firm: The Case of Petroleum Pricing in the Late 1970s,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The Quarterly Journal of Economics, 105(1): 115-34.",
        "Ellison, Sara Fisher and Catherine Wolfram. 2006. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Coordinating on Lower Prices: Pharmaceutical Pricing under Political Pressure,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The RAND Journal of Economics, 37(2): 324-340.",
        "Ellison, Glenn and Sara Fisher Ellison. 2010. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d American Economic Journal: Microeconomics 3(1): 1-36.",
        "Finkelstein, Amy. 2004. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Static and Dynamic Effects of Health Policy: Evidence from the Vaccine Industry.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Quarterly Journal of Economics, 527-564.",
        "Fisman, Ray and Shang-Jin Wei. 2004. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Tax Rates and Tax Evasion: Evidence from \u00c3\u00a2\u00e2\u0082\u00ac\u00cb\u009cMissing Imports\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 in China,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Political Economy, 112(2): 471-496.",
        "Gallini, Nancy. 2002. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Economics of Patents: Lessons from Recent U.S. Patent Reform.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Economic Perspectives 16 (2): 131-154.",
        "Glazer, Amihai and Henry McMillan. 1992. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Pricing by the Firm Under Regulatory Threat,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The Quarterly Journal of Economics, 107(3): 1089-99.",
        "Goldberg, Pinelopi K. 2010. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Intellectual Property Rights Protection in Developing Countries: The Case of Pharmaceuticals.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of the European Economic Association 8: 326-353.",
        "Goolsbee, Austen and Chad Syverson. 2008. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093How do Incumbents Respond to the Threat of Entry? Evidence from the Major Airlines,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Quarterly Journal of Economics, 123(4): 1611-1633 Greene, William. 2007. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Emergence of India\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s Pharmaceutical Industry and Implications for the U.S. Generic Drug Market,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d United States International Trade Commission, No. 2007-05-A.",
        "Harris, Gardiner and Katie Thomas. 2013. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Low Cost Drugs in Poor Nations Get a Lift in Indian Court,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The New York Times, April 1, 2013.",
        "Hason, Averie and Jean Shimotake. 2006. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Recent Developments in Patent Rights for Pharmaceuticals in China and India,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Pace International Law Review, 18(1): 303-315.",
        "IMS Health. 2012. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Global Use of Medicines: Outlook through 2016,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d available at: http://www.imshealth.com/deployedfiles/ims/Global/Content/Insights/IMS%20Institute%20f or%20Healthcare%20Informatics/Global%20Use%20of%20Meds%202011/Medicines_Outlook _Through_2016_Report.pdf.",
        "Kallummal, Murali and Kavita Bugalya. 2012. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Trends in India\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s Trade in Pharmaceutical Sector: Some Insights,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Center for WTO Studies.",
        "Kremer, Michael and Heidi Williams. 2010. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Incentivizing Innovation: Adding to the Toolkit.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Innovation Policy and the Economy 10: 1-17.",
        "Kurzius, Alexa. 2013. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The power of patents: Advocacy groups fear a win for Novartis in India\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s patent law case will affect affordable access to medicine worldwide,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d ScienceLine, available at: http://scienceline.org/2013/01/the-power-of-patents/.",
        "Kyle, Margaret and Anita McGahan. 2012. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Investments in Pharmaceuticals Before and After TRIPS,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Review of Economics and Statistics, 94(4): 1157-1172.",
        "Kyle, Margaret and Yi Qian. 2014. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Intellectual Property Rights and Access to Innovation: Evidence from TRIPS,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d working paper.",
        "LaCroix, S., and M. Liu. 2008. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Patents and Access to Essential Medicines\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d chap. 13, pp. 423464. Frontiers of Economics and Globalization. Elsevier.",
        "Langer, Eric and Abhijeet Kelkar. 2008. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Pharmaceutical Distribution in India,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d BioPharm International.",
        "Lanjouw, J., & Cockburn, I. 2001. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Do Patents Matter? Empirical Evidence After GATT,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d NBER Working Paper 7495 .",
        "Mclain, Sean. 2014. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093India Imposes Price Controls on Diabetes and Heart-Disease Drugs,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Wall Street Journal, July 14,2014.",
        "Milgrom, Paul and John Roberts. 1982. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Limit Pricing and Entry Under Incomplete Information: An Equilibrium Analysis,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Econometrica, 50(2): 443-459.",
        "Moser, Petra. 2005. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093How Do Patent Laws Influence Innovation? Evidence from NineteenthCentury World Fairs,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The American Economic Review, 95( 4): 1214-1236 Mueller, Janice. 2006. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Tiger Awakens: The Tumultuous Transformation of India&apos;s Patent System and the Rise of Indian Pharmaceutical Innovation,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d University of Pittsburg Law Review, 68: 491-642.",
        "Narendranath, K.A. 2005. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Patent mailbox opens, Pfizer is top applicant,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The Financial Express, March 21, 2005.",
        "Nordhaus, William. 1969. Invention, Growth and Welfare: A Theoretical Treatment of Technological Change. Cambridge Mass.: MIT Press.",
        "Saha, Debabrata. 2004. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Proposal for Establishing a Development Agenda for WIPO,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d accessed online on 8/30/2014 at: http://www.cptech.org/ip/wipo/india10012004.html.",
        "Silverman, Ed. 2014. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Gilead Will Charge $900 for Hepatitis C Treatment in India,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Wall Street Journal, Aug 8, 2014.",
        "Sampat, Bhaven. 2010. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Institutional Innovation or Institutional Imitation? The Impacts of TRIPs on India\u00c3\u008a\u00c2\u00bcs Patent Law and Practice,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d working paper."
    ]
}